KENDAL PACKER: Open Payments
NPI 1023566817 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,598 in 145 payments from 17 companies in 2025. Trend: 2023 $1,171 · 2024 $1,442 · 2025 $2,598
Food & beverage: $2,458Education: $140
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 21 | $424 |
| ABBVIE INC. | 19 | $294 |
| Janssen Biotech, Inc. | 13 | $275 |
| Lilly USA, LLC | 14 | $249 |
| Novartis Pharmaceuticals Corporation | 15 | $215 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $180 |
| Amgen Inc. | 10 | $173 |
| PFIZER INC. | 10 | $158 |
| Galderma Laboratories, L.P. | 14 | $153 |
| LEO Pharma Inc. | 4 | $101 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, EBGLYSS, Otezla, CIBINQO, NEMLUVIO, COSENTYX.
Industry payments across AZ — which companies pay providers there.
